UNDER THE RADAR

HHS Nominee Vows To Tackle High Drug Costs, Despite His Ties To Industry

Alex M. Azar II, the former president of the U.S. division of Eli Lilly, says the U.S. drug system encourages price increases — but he intends to work on that problem.